Resources & Blog

Show All
  • Show All
  • Health Plans
  • Providers
  • Uncategorized

01-06-2022

Case Study: Impact of Mosaic on Health Spending, Unplanned Care, and Medication Adherence

Mosaic Pharmacy Service is disrupting the idea of traditional pharmacy care. This tech-enabled pharmacy addresses medication overload and compounding challenges of confusion, waste, adverse events, and preventable costs among health plans’ most medically complex and vulnerable Medicare members, with Mosaic members experiencing a reduction in medical spend, improved adherence on all three CMS Star Ratings adherence measures, and reduced unplanned care events. Read the full case study here.

12-21-2021

Targeted Pharmacy Care Drives Star Ratings & Improves Health Outcomes

Mosaic presented at the 2021 Medicare Star Ratings & Quality Assurance Summit on the role of high-value pharmacy services in improving health plans’ pharmacy quality ratings.

11-15-2021

Identifying High-Need Populations and Delivering Clinical Pharmacy Care to Drive Outcomes

Watch Mosaic's presentation on the role and positive outcomes of value-based pharmacy services, presented at the 2021 Pharmacy Innovations Conference.

11-10-2021

How does medication use drive Star Ratings?

We're always talking about the importance of medication adherence in ensuring high Star Ratings, and recent industry performance data illustrates this relationship firsthand. Using the interactive RxAnte Star Ratings Tool, you can view the correlation between MAPD and PDP plan Star Ratings and medication adherence rates. Curious about how you stack up against similar plans? Set the measure-specific performance sliders to your plans’ Star Ratings to see how you compare.

10-27-2021

Pharmacy Innovations For Medicare, Medicaid & Duals Plans (November 9, 2021)

Join RxAnte at the Pharmacy Innovations Conference on November 9th. This event for Medicare, Medicaid & Duals Plans will cover proven end-to-end solutions to control costs, adopt new technologies, and ensure compliance with rapidly evolving regulations.

09-30-2021

2022 Star Rating Cut Points: What Do They Mean for Your Health Plan?

Each year as Q4 approaches, Medicare Advantage Part D (MAPD) health plans await the release of updated cut points for the approaching Star Year to understand how these changes will impact their Star Ratings. CMS recently released the new 2022 Star Rating cut points, and RxAnte’s client analytics team will be hard at work providing an updated in-depth industry analysis to account for the impact of these changes on MAPD plans’ Star Rating performance.

08-26-2021

Answering Frequently Asked Questions with Mosaic’s Director of Clinical Services (Part 2)

In last month's blog post, we highlighted the common barriers that Sapna Patel, RPh, Director of Clinical Services, at Mosaic Pharmacy Services sees on a regular basis. We continue our series with additional observations that Sapna and her team experience frequently while trying to support better health outcomes for Mosaic members.

08-13-2021

AHIP Webinar: High-Value Pharmacy Services for Medically Complex Members (September 29, 2021)

RxAnte will be participating in an hour long webinar, sponsored by AHIP, to discuss how tech-enabled, high-value pharmacy services are improving the pharmacy experience for medically complex Medicare members that are at risk for suboptimal medication use.

07-28-2021

Answering Frequently Asked Questions with Mosaic’s Director of Clinical Services

As the Director of Clinical Services at Mosaic Pharmacy Service, Sapna Patel, RPh, is responsible for overseeing the development and delivery of clinical services for all Mosaic members. This month we asked Ms. Patel to share insights on the most common challenges and scenarios her team experiences when working with members and how Mosaic’s high-value pharmacy service helps to support better health outcomes moving forward.

06-22-2021

Addressing the New Polypharmacy Display Measures

Polypharmacy is a familiar topic for many when discussing adherence and prescribing behavior. With the addition of three polypharmacy-related display measures for the 2022 CMS quality measure performance year, we turned to Tori Erxleben Rush, PharmD, RxAnte Product Director, to learn more about the display measures and their significance to health plans and their members .